© 2021 MJH Life Sciences and Contagion Live. All rights reserved.
© 2021 MJH Life Sciences™ and Contagion Live. All rights reserved.
June 29, 2018
The rise of ID pharmacy as a profession has been complementary to services uniquely offered by ID physicians, not in competition with them.
Stewardship & Prevention
Although challenging, it is not impossible to change some outlier behaviors.
The updated guidelines recommend targeting those with active infection and avoiding treatment of “carriers” of C difficile who are colonized but not symptomatic.
June 28, 2018
Experts continue to recommend that people get the seasonal flu vaccine as the scientific community works toward a universal vaccine offering lifelong protection against multiple strains.
MJH Associates, Inc & the FDA are both committed to eliminating inefficiencies and hype to deliver the most timely and relevant information to health care providers.
In the Literature
Preliminary studies provide convincing evidence for the synergistic use of sulfonamide agents with azole antifungals.
Because of the global rise in antimicrobial resistance, meropenem-vaborbactam, the first carbapenem/β-lactamase combina­tion medication, is a welcome new antibac­terial.
June 26, 2018
Early diagnosis and treatment were essential to ensuring a good prognosis.
June 25, 2018
Emerging & Re-Emerging Infections
The emergence of new species creates pressure for developing affordable and reliable diagnostic strategies.
June 22, 2018
Patient and institutional history, as well as the individual niches of the new antibiotics, need to be considered when selecting a treatment for gram-negative infections.
June 21, 2018
News and Breakthroughs
Several recent studies provide valuable insight surrounding the appropriateness of transitioning from intravenous to oral therapy when treating bacteremic urinary tract infections.
June 20, 2018
Feature - HIV
Implants are promising for long-term, sustained, and reversible delivery of ARV drugs that may bypass adherence challenges for end users.
June 19, 2018
An increase in injection drug use in the United States has augmented the likelihood of acquiring HCV, particularly genotype 3.